Original Article

Outcomes of Lobar and Sublobar Resections for Non--Small-Cell Lung Cancer: A Single-Center Experience

Authors: Daniel Kim, MS, Victor A. Ferraris, MD, PhD, Daniel Davenport, PhD, Sibu Saha, MD, MBA

Abstract

Objectives: Lung cancer is the leading cause of cancer-related mortality in the United States. Kentucky has the highest age-adjusted lung cancer rate and has one of the highest death rates from lung cancer in the country. Lobectomy is considered the standard therapy for non–small-cell lung cancer (NSCLC), whereas sublobar resection remains an option for selected patients. We investigated outcomes in patients having standard resections for lung cancer (lobectomy) compared with those having sublobar resections in a population with high prevalence of, and with a high death rate from, lung cancer.

Methods: We studied patients having lung cancer resections at the University of Kentucky between 2002 and 2007. We reviewed the records of 222 patients who had either lobar or sublobar resections for NSCLC. This retrospective review identified key outcome variables, as well as short- and long-term survival. Propensity analysis allowed outcome comparison between patients having lobar and sublobar resections matched for preoperative variables.

Results: Of the 222 study patients, 181 patients had lobectomies and 41 had sublobar resections. For all resections, lobectomy was associated with improved 1-, 3-, and 5-year survival rates compared with sublobar resections. Compared with patients having sublobar resections, lobectomy patients had significantly increased unadjusted perioperative morbidity (43.1% lobectomy vs 7.3% sublobar), but not mortality. After propensity analysis, sublobar resection predicted significantly reduced morbidity (6.3% vs 53.3%, P < 0.001), but not operative mortality (3.3% vs 3.3%, P = not significant), compared with lobectomy in patients matched for age, sex, cancer stage, and date of operation. Adjuvant chemotherapy combined with radiation therapy showed significantly improved long-term survival for either type of resection. Cox regression with adjustment for age, cancer stage, and postoperative complications suggested that neoadjuvant chemotherapy/radiotherapy increased long-term survival ( P = 0.038, hazard ratio 0.49).

Conclusions: Sublobar resections for NSCLC have less morbidity compared with lobectomy, but at the cost of decreased long-term survival. These results imply that surgeons select patients for lobar or sublobar resections based on physiologic and functional parameters, and that differences in outcomes between these two groups reflect this selection bias. We suspect that these results are typical of surgical treatment of NSCLC in a heterogeneous high-risk population with a high penetration and prevalence of lung cancer.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. American Cancer Society. Estimated number of new cancer cases and deaths, US, 2014. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014. Accessed March 10, 2015.
 
2. Watanabe S, Asamura H, Suzuki K, et al. Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004;78:999-1003.
 
3. Wolf AS, Richards WG, Jaklitsch MT, et al. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg 2011;92:1819-1825.
 
4. Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983;86:654-658.
 
5. National Cancer Institute/Centers for Disease Control and Prevention. State cancer profiles. http://statecancerprofiles.cancer.gov. Accessed March 10, 2015.
 
6. Ferraris VA, Davenport DL, Saha SP, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012;147:49-55.
 
7. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009;28:3083-3107.
 
8. Austin PC. The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies. Stat Med 2010;29:2137-2148.
 
9. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 2007;134:1128-1135.
 
10. Austin PC. Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses. Int J Biostat 2009;5:article 13.
 
11. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-623.
 
12. Harpole DH Jr, DeCamp MM Jr, Daley J, et al. Prognostic models of thirty-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg 1999;117:969-979.
 
13. Whitson BA, Groth SS, Duval SJ, et al. Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann Thorac Surg 2008;86:2008-2018.
 
14. Li Y, Wang J. Comparison of clinical outcomes for patients with clinical N0 and pathologic N2 non-small cell lung cancer after thoracoscopic lobectomy and open lobectomy: a retrospective analysis of 76 patients. J Surg Oncol 2012;106:431-435.
 
15. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006;82:408-416.
 
16. Cahan WG. Radical lobectomy. J Thorac Cardiovasc Surg 1960;39:555-572.
 
17. Shimkin MB, Connelly RR, Marcus SC, et al. Pneumonectomy and lobectomy in bronchogenic carcinoma. A comparison of end results of the Overholt and Ochsner clinics. J Thorac Cardiovasc Surg 1962;44:503-519.
 
18. De Zoysa MK, Hamed D, Routledge T, et al. Is limited pulmonary resection equivalent to lobectomy for surgical management of stage I nonsmall-cell lung cancer? Interact Cardiovasc Thorac Surg 2012;14:816-820.
 
19. Stefani A, Nesci J, Casali C, et al. Wedge resection versus lobectomy for T1N0 non-small cell lung cancer. Minerva Chir 2012;67:489-498.
 
20. Chamogeorgakis T, Ieromonachos C, Georgiannakis E, et al. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients? Interact Cardiovasc Thorac Surg 2009;8:364-372.
 
21. American Lung Association. Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. http://www.lung.org/finding-cures/our-research/trend-reports/copd-trend-report.pdf. Published March 2013. Accessed March 10, 2015.
 
22. Centers for Disease Control and Prevention. Addition of prevalence of cigarette smoking as a nationally notifiable condition--June 1996. MMWR Morb Mortal Wkly Rep 1996;45:537.
 
23. Abolhoda A, Liu D, Brooks A, et al. Prolonged air leak following radical upper lobectomy: an analysis of incidence and possible risk factors. Chest 1998;113:1507-1510.